Healthcare Upside/Down: Healthcare’s Asymmetry of Information with Pramod John, CEO of Vivio Health

Published: Jan. 18, 2022, midnight

S1E9: Healthcare’s Asymmetry of Information with Pramod John, CEO of Vivio Health, and host Dr. Nick. Do you know if the drugs you are prescribed and are taking are actually delivering value? Who has your best interests front and center and you trust to make a determination and guide the clinical decision-making process on what therapy is indicated for the disease in you? If you were leaning on the FDA, recent news and events might give you pause. Recently conditionally approved Aduhelm an Alzheimer treatment by Biogen is controversial and pricey. Medicare premiums at all time high in part from the impact of Aduhelm. So what about the information and data available, the science? Drug pricing is outstripping our ability to pay, and a large portion of these escalating costs is linked to specialty drugs that can account for as much as 50% of costs while only treating a small percentage of patients. Your better pill to swallow, we can no longer accept the value of a treatment based on it being prescribed and our assumption that all the processes in place make this choice the right choice for you since the assumptions are not aligned with yours and in fact may be counter. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play HealthcareNOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen